Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-12-11

Clinical Trial Update: Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating riluzole for surgically resectable stage III or stage IV melanoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Riluzole (riluzole)

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Melanoma (Skin) | Phase 1 | Status: TERMINATED